Stefania Cavazzini
University of Parma
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stefania Cavazzini.
Journal of Chromatography B: Biomedical Sciences and Applications | 2000
Paola Manini; Roberta Andreoli; Stefania Cavazzini; Enrico Bergamaschi; Antonio Mutti; W.M.A. Niessen
A new method based on liquid chromatography-tandem mass spectrometry has been developed for the determination of monoamine metabolites, i.e., homovanillic acid (HVA), vanilmandelic acid (VMA), 3,4-dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindoleacetic acid (5-HIAA) in human urine. Analytes were separated on a C16 amide (5 cm, 5 microm) column and ionized by negative ion electrospray. Operating in the selected-reaction monitoring mode, linearity was established over three-orders of magnitude and limits of detection were in the range 30-70 microg/l. Precision calculated as RSD was within 0.8-5.2% for all intra- and inter-day determinations. The method was applied to the quantitative analysis of monoamine metabolites in 700 urine samples from occupationally (adults) and environmentally (both children and adults) exposed people living in areas with different soil contamination from lead. The urinary excretion of monoamine metabolites was significantly higher (P<0.001) in the subgroup of children living in polluted areas as compared to the control group (HVA, 6.03 vs. 4.57 mg/g creatinine; VMA, 5.33 vs. 4.37 mg/g creatinine; 5-HIAA 3.24 vs. 2.45 mg/g creatinine). In adults belonging to both groups of subjects occupationally and environmentally exposed, no differences were detected in the urinary concentration of monoamine metabolites. However, adults showed lower values of HVA (2.57 mg/g creatinine), VMA (2.17 mg/g creatinine) and 5-HIAA (2.09 mg/g creatinine) as compared to children groups.
Journal of Hypertension | 2007
Aderville Cabassi; Simona Dancelli; Paolo Pattoneri; Giovanni Tirabassi; Fabio Quartieri; Luigi Moschini; Stefania Cavazzini; Roberta Maestri; Costanza Lagrasta; Gallia Graiani; Domenico Corradi; Elisabetta Parenti; Stefano Tedeschi; Elena Cremaschi; Pietro Coghi; Simonetta Vinci; Enrico Fiaccadori; Alberico Borghetti
Objective and methods Left ventricular hypertrophy in human and experimental hypertension is not always associated with pressure overload but seems to precede an increase in blood pressure. In this study, performed in male 5-week-old prehypertensive spontaneously hypertensive rats (SHR; n = 65) and age-matched Wistar–Kyoto rats (n = 56), the relationship between myocardial structure and activation of the adrenergic and nitric oxide systems was evaluated. Results Body weight, blood pressure and heart rate were similar in both groups. A higher left ventricle/body weight ratio was found in SHR, as a result of greater mononuclear (+47%) and binuclear (+43%) myocyte volumes, without changes in interstitial collagen. Both adrenergic and nitric oxide pathways were activated in SHR, as expressed by higher myocardial norepinephrine content, tyrosine hydroxylase activity, myocardial nitric oxide synthase 3 expression and protein nitration, indicating greater peroxynitrite (ONOO−) generation from nitric oxide and superoxide. No difference was measured in nitric oxide synthase 1 expression, whereas nitric oxide synthase 2 was undetectable. A positive correlation between myocardial tyrosine hydroxylase activity and protein nitration was observed in SHR (r2 = 0.328; P < 0.01). Early treatment with a superoxide dismutase mimetic, 4-hydroxy-2,2,6,6-tetramethyl piperidinoxyl, from the third to the fifth week of age, reduced ONOO− generation, protein nitration and sympathetic activation in SHR without changes in myocardial structure. Conclusion In prehypertensive SHR, left ventricular hypertrophy is associated with adrenergic and nitrosative imbalance. Early superoxide dismutase mimetic treatment in SHR effectively reduces higher myocardial ONOO− generation, sympathetic activation, and heart rate without affecting the development of myocardial hypertrophy.
Toxicology Letters | 2002
Massimo Corradi; Rossella Alinovi; Matteo Goldoni; Maria Vittoria Vettori; Giuseppina Folesani; Paola Mozzoni; Stefania Cavazzini; Enrico Bergamaschi; Licia Rossi; Antonio Mutti
The Journal of Clinical Endocrinology and Metabolism | 2005
Aderville Cabassi; Pietro Coghi; Paolo Govoni; Elisa Barouhiel; Ester Speroni; Stefania Cavazzini; Anna Maria Cantoni; Renato Scandroglio; Enrico Fiaccadori
Chemical Research in Toxicology | 2001
De Palma G; Paola Manini; Paola Mozzoni; Roberta Andreoli; Enrico Bergamaschi; Stefania Cavazzini; I. Franchini; Antonio Mutti
Hypertension | 2002
Aderville Cabassi; Simonetta Vinci; Anna Maria Cantoni; Fabio Quartieri; Luigi Moschini; Stefania Cavazzini; Angelo Cavatorta; Alberico Borghetti
Toxicology Letters | 1999
Enrico Bergamaschi; A. Brustolin; G De Palma; Paola Manini; Paola Mozzoni; Roberta Andreoli; Stefania Cavazzini; Antonio Mutti
International Archives of Occupational and Environmental Health | 1997
Enrico Bergamaschi; Audrey Smargiassi; Antonio Mutti; Stefania Cavazzini; Maria Vittoria Vettori; Rossella Alinovi; I. Franchini; Donna Merglera
Neurotoxicology | 1996
Enrico Bergamaschi; A. Mutti; Stefania Cavazzini; Maria Vittoria Vettori; Renzulli Fs; I. Franchini
Neurotoxicology | 2000
Maria Vittoria Vettori; Domenico Corradi; Teresa Coccini; Carta A; Stefania Cavazzini; Luigi Manzo; Antonio Mutti